CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,457,000 | +25.5% | 1,175,000 | +82.3% | 0.61% | +23.1% |
| Q4 2021 | $23,463,000 | -51.3% | 644,400 | -31.5% | 0.50% | -62.6% |
| Q1 2021 | $48,207,000 | +2.8% | 940,800 | +24.3% | 1.33% | -12.5% |
| Q4 2020 | $46,873,000 | +26.1% | 757,000 | +17.2% | 1.52% | -36.1% |
| Q2 2020 | $37,159,000 | +291.9% | 645,800 | +173.6% | 2.38% | +81.8% |
| Q1 2020 | $9,482,000 | – | 236,000 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |